The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control
about
Role of cues and contexts on drug-seeking behaviourModels of Impulsivity with a Focus on Waiting Impulsivity: Translational Potential for Neuropsychiatric DisordersReward-Induced Eating: Therapeutic Approaches to Addressing Food CravingsNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Noribogaine reduces nicotine self-administration in rats.Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference BehaviorCharacterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity.Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in ratsDirectly Observable Behavioral Effects of Lorcaserin in RatsLorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys.Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.Development of novel pharmacotherapeutics for tobacco dependence: progress and future directionsSynthesis and evaluation of methylated arylazepine compounds for PET imaging of 5-HT(2c) receptors.Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.Orexin receptors within the nucleus accumbens shell mediate the stress but not drug priming-induced reinstatement of morphine conditioned place preferenceA novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.Activation of Ventral Tegmental Area 5-HT2C Receptors Reduces Incentive Motivation.New obesity agents: lorcaserin and phentermine/topiramate.Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial.Translatable and Back-Translatable Measurement of Impulsivity and Compulsivity: Convergent and Divergent Processes.A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study.Characterization of the discriminative stimulus effects of lorcaserin in rats.On the Role of Cannabinoid CB1- and μ-Opioid Receptors in Motor Impulsivity.The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour.Behavioral, pharmacological and neuroanatomical analysis of serotonin 2C receptor agonism on maternal behavior in rats.Impulsive action in the 5-choice serial reaction time test in 5-HT₂c receptor null mutant mice.Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles.Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates.The dopamine motive system: implications for drug and food addiction.Increasing motor neuron excitability to treat weakness in sepsis.Pharmacological Modulation of 5-HT2C Receptor Activity Produces Bidirectional Changes in Locomotor Activity, Responding for a Conditioned Reinforcer, and Mesolimbic DA Release in C57BL/6 Mice.Inhibition of cocaine and 3,4-methylenedioxypyrovalerone (MDPV) self-administration by lorcaserin is mediated by 5-HT2C receptors in rats.Effects of Lorcaserin on Cocaine and Methamphetamine Self-Administration and Reinstatement of Responding Previously Maintained by Cocaine in Rhesus Monkeys.Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists.The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.
P2860
Q26825476-EA5CC5BD-79B7-4A86-B387-0BF107E2A44BQ27024507-1165ACDF-59F3-4900-9EBF-467A61510A3CQ28074195-AC6FF47B-FCD0-4125-BF68-61F1004DC1CBQ28277165-B11C7590-1889-4C39-A086-FF148E62AEE1Q30653279-79D9C98E-C47B-46B8-9F41-4DE4D80C9876Q33874819-A655B70A-E160-424E-B33C-40C47F666917Q34359231-FB52519D-11A5-4D13-8C42-53A358FF385DQ34407185-48EC0D60-082A-44B8-8A82-CFC12A6DA796Q34501087-80AC0F1F-72BE-4295-9001-B64F7E35E8DAQ35049574-D303F9CB-8941-4A23-84FC-2E79BF2CE703Q35952202-DE6B3AA6-A040-47FA-900F-F10FC9C6D51BQ36316458-52E0ABE3-ABE1-4B81-A52A-97C5ECFDF1AFQ36432310-921607C1-138F-4248-989C-1B4966BE89B0Q36568217-6948EB4A-640B-44B1-AD45-C93A50E56C17Q36727844-68D8863F-8F10-4547-8595-1529CED436EEQ37116006-FF0EF4F1-2F3A-47A4-8E64-98DE9C7E538DQ37200551-0FF6E5AF-B57A-49C6-9CCA-DF07D88506FAQ37223840-BE2FE7ED-A612-44AC-BAE2-28A05312E61DQ37707718-56B96E40-D70F-47B6-92D9-2450D29DABBCQ37716024-481C1542-C1A5-4569-9730-8792D4231026Q38117028-41C9AADC-6ED9-4A04-9A65-EA8BE64D0902Q38385068-0EE9008D-2E0F-4822-AFB2-FF09628A074EQ38897357-77C48D60-13FC-4874-B9B4-38E95E385AFAQ39164871-9760D1F0-8EED-49E2-9283-4B8AD2A28B56Q39182453-F0EF440C-3392-4B60-9421-4E983AF705D3Q41233440-08F7ED16-1976-4CBC-884B-05164623C4ABQ41811043-0E9A3D80-A5C7-47C4-9DE2-C7E077526FDCQ41910031-ECD3E1C9-B23F-4C7E-BB45-7F1AA7C0BFAAQ42647430-DC0E880F-EEA9-4BB1-AEA5-0C7FA9B94F41Q44444183-6417C0B7-6D4D-4AE1-A4B0-BAD3BA8E1092Q45051146-D5C1564A-ADF0-4F3E-A02A-BFFA7FD595C1Q46240693-3D18B0CB-6236-427D-98E5-5E3635FFB6ECQ46282660-F7BB6517-FB1B-4DE5-B943-DE7ECD08B87DQ47307050-A94AEB42-25CC-4649-9A20-9553979FD0FCQ47317465-6DDF5D09-79C5-4846-B8D7-FAEBBC54BE48Q47330880-77C4AADA-8D5C-4916-B3AB-E39C057A1AE8Q47348330-C6351913-2167-48D3-A5BF-8509F9B15307Q47373147-C2CAE408-614D-4825-ACE3-76758B875616Q47588598-2E509C27-33F2-4B73-9D26-07AA9038E338Q47677518-478DC2ED-21D9-4C75-BA75-EE48582938C2
P2860
The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@ast
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@en
type
label
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@ast
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@en
prefLabel
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@ast
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@en
P2093
P2860
P356
P1476
The 5-HT2C receptor agonist lo ...... g behavior and impulse control
@en
P2093
Anne Rossmann
Ashlie D Soko
Guy A Higgins
Kevin Noble
Leo B Silenieks
Paul J Fletcher
P2860
P2888
P304
P356
10.1038/NPP.2011.303
P407
P577
2011-12-21T00:00:00Z